What is Lohman Technologies?
Lohman Technologies, founded by the Lohman family, is a pioneer in remote cardiac monitoring, building upon the legacy of the Cardiac Evaluation Center (CEC) established in 2014. The company is dedicated to improving the means by which patients with heart arrhythmias are monitored and diagnosed. Their mission centers on enhancing mobile cardiac monitoring to provide peace of mind to patients and elevate the quality of care delivered by physicians and healthcare organizations. Key innovations include the patented Genesis ECG Memory Loop Recorder, featuring 30-day memory loop technology for capturing transient heart arrhythmias, and the AfibAlert® Concept & Design, a lightweight, hand-held monitor for instant ECG data analysis and feedback on present arrhythmias. Additionally, Lohman Technologies has developed patented Polarity-Correcting DC-to-DC Converter technology, ensuring reliable battery function in devices.
How much funding has Lohman Technologies raised?
Lohman Technologies has raised a total of $20K across 1 funding round:
Debt
$20K
Debt (2021): $20K with participation from PPP
What's next for Lohman Technologies?
With substantial expansion capital, Lohman Technologies is poised for significant advancements in its product development and market reach. The company's strategic focus on patented technologies for arrhythmia detection and remote monitoring suggests a trajectory towards broader adoption within the healthcare industry. Future growth is likely to involve scaling manufacturing, enhancing software capabilities for data analysis, and expanding clinical partnerships to further validate and integrate their solutions. This latest round of investment will be critical in solidifying Lohman Technologies' position as a leader in innovative cardiac care.
See full Lohman Technologies company page
